MDLinx Neuro Brief

Dangerous effects of hypertension on neuro patients, a common neurological condition is often misdiagnosed, and a natural hormone could predict Alzheimer’s

As flu season ramps up, everyone’s keeping their eyes on COVID-19 numbers, especially patients with neurologic disease and the doctors who treat them. Every day our understanding of how the pandemic impacts these patients becomes clearer, and the image is pretty scary—fitting for the Halloween season. This week we offer insights into how the pandemic…

Approved neuro drugs could have deadly consequences, genetic variation linked to cognitive decline, and new Alzheimer’s biomarker key to early detection

World Alzheimer’s Day arrived last week and brought with it a host of new research into the world’s most common form of dementia. We’re celebrating with an influx of new dementia insights, including the condition’s ancient history, two new cutting-edge biomarkers, and a pandemic-related condition that doubles its risk. Plus, shocking new data on your…

New Alzheimer’s drug class on the horizon, recent findings could upend long-established guidelines, and an unconventional way to skirt MS symptoms

Between a brand new class of drugs, revelations about ties to pregnancy, updates on off-label drug use, and a slew of new data on disease-modifying therapies, it was a fast-paced week in the world of multiple sclerosis. We’ll keep you abreast of the latest breakthroughs, plus many more from across the world of neurology—like new…

×